Survival Outcomes and Prognostic Value of Nutritional and Inflammatory Markers in Third-Line Treatment of Metastatic Pancreatic Cancer

By:
Júlia Vidulin; Dalibor Ondruš; Štefan Pöršök; et al.
Date:
2026
Resource type:
Peer review
Link:
Survival Outcomes and Prognostic Value of Nutritional and Inflammatory Markers …

This study shows that third-line chemotherapy can provide limited survival benefits in metastatic pancreatic cancer, with outcomes strongly influenced by nutritional and inflammatory status. Higher Prognostic Nutritional Index (PNI) and lower Glasgow Prognostic Score (GPS) were linked to longer survival, highlighting their value in identifying patients most likely to benefit from further treatment.